(RTTNews) - Amneal Pharmaceuticals, Inc. (AMRX) announced that the U.S. Food and Drug Administration has approved its iohexol injection (300 mg Iodine/mL), the first generic version of GE Healthcare's ...
(RTTNews) - Amneal Pharmaceuticals Inc. (AMRX) announced that the U.S. Food and Drug Administration has approved its iohexol injection (300 mg Iodine/mL), marking the first generic version of GE ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Iohexol 647mg (equivalent to 300mg of organic iodine) per mL; soln; preservative-free. Intrathecal administration: in adults, for myelography (lumbar, thoracic, cervical, total columnar) and ...
Iohexol 755mg (equivalent to 350mg of organic iodine) per mL; soln; preservative-free. IV administration: in adults, for angiocardiography (ventriculography, selective coronary arteriography), ...
Amneal Pharmaceuticals (AMRX) just received U.S. FDA approval for its iohexol injection, paving the way for the first generic alternative to Omnipaque in a $652 million market. This milestone arrives ...
(MENAFN- GlobeNewsWire - Nasdaq) First-to-market complex injectable with expected launch in Q1 2026 BRIDGEWATER, N.J., Nov. 13, 2025 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. (“Amneal” or ...
BRIDGEWATER, N.J., Nov. 13, 2025 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. (“Amneal” or the “Company”) (Nasdaq: AMRX) today announced the U.S. Food and Drug Administration (FDA) has approved ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results